SF3B1 and papillary carcinoma: To address these questions, the 19 papillary carcinomas were subjected to targeted DNA re-sequencing of SF3B1 exons 14–16 and of nine additional genes, which are recurrently mutated in ER-positive breast cancers harbouring SF3B1 mutations and have been postulated as drivers [5].